logo
Select company
Select metric
-205.52%Return on Equity
VS
Market
6
Sector
18
Industry
22
History
-
$ 6.35Close
$ 3.24 - $ 18.48 52-Week Range
Ticker Information

Ticker

NXTC

Company Name

NEXTCURE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEXTCURE INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NXTC - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 29.65M$ -60.93M-205.52%
3/31/2025$ 55.85M$ -49.52M-88.66%
12/31/2024$ 65.47M$ -55.65M-85%
9/30/2024$ 75.59M$ -58.52M-77.41%
6/30/2024$ 85.44M$ -61.28M-71.72%
3/31/2024$ 99.05M$ -63.73M-64.35%
12/31/2023$ 114.42M$ -62.72M-54.82%
9/30/2023$ 126.45M$ -65.56M-51.84%
6/30/2023$ 138.43M$ -70.17M-50.69%
3/31/2023$ 154.2M$ -70.23M-45.54%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for NEXTCURE INC is calculated as follows: Net Inc. Cmn. [ $ -32.07M ] / Equity [ $ 307.34M ]
(=) ROE [ -10.43% ]

NXTC - Return on Equity, Last 5 years

-205.52%

Minimum

Jun 30, 2025

-10.43%

Maximum

Sep 30, 2020

-54.01%

Average

-45.08%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%